Navigation Links
Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
Date:5/4/2009

es for the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at www.sangamo.com.

This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to the research and development of novel ZFP TFs and ZFNs, human, plant and research applications of Sangamo's ZFP technology platform, strategic partnerships with collaborators and clinical trials of ZFP Therapeutics. Actual results may differ materially from these forward-looking statements due to a number of factors, including technological challenges, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent report on Form 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
2. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
3. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
4. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
5. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
6. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
7. Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
9. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
10. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
11. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... 2014 The Registration Committee today ... now open for Pittcon 2015, the world’s largest ... event will be held March 8-12, 2015, at ... , The discounted registration fee of $175 ... 2/20/2015). This affordable price includes unlimited week-long access ...
(Date:9/11/2014)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... it intends to conduct a Private Placement to ... its preclinical development activities and financial commitments to ... The Company is proposing to complete a non-brokered ... at a price of US$0.10 per Share, for ...
(Date:9/11/2014)... Awarded annually by Germany’s Design Zentrum Nordrhein-Westfalen, ... quality label for excellent design. METTLER TOLEDO is ... Red Dot award in recognition of high ... (HPD). , The Quantos Handheld Powder Dispenser ... to applications involving free-flowing powders. Forget the delicacy ...
(Date:9/11/2014)... and LONDON , ... Cancer Research Technology (CRT), the charity,s development and ... (OTCBB: ASTY), a biotechnology company in the emerging ... novel immunotherapy treatment AST-VAC2 into clinical trials in ... AST-VAC2 represents the tenth treatment to enter Cancer ...
Breaking Biology Technology:Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4METTLER TOLEDO Handheld Powder Receives Red Dot Award for Product Design 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 4Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 5Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 6Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 7Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 8
... Ariz., April 4, 2012  MedPlast, Inc., a technology ... Healthcare and Industrial specialty markets, announces the acquisition ... a world-class, full-service manufacturer of precision plastic products ... Datacenter markets, with operations in the U.S., China, ...
... Lian, assistant professor in the Department of Mechanical, Aerospace, ... a prestigious Faculty Early Career Development Award (CAREER) from ... the five-year, $500,000 award to further his research into ... systems. The CAREER Award is given to faculty members ...
... April 3, 2012  Oxford Finance LLC ("Oxford"), a specialty ... and healthcare services companies, today announced a $15 million ... The financing package, which was awarded to NanoString from ... million senior secured term loan and a $2 million ...
Cached Biology Technology:MedPlast Acquires UPG 2MedPlast Acquires UPG 3Rensselaer professor Jie Lian receives NSF CAREER Award 2Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies 2Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies 3
(Date:9/11/2014)... Northeastern University researchers and their international colleagues have ... role of neutral evolution in the biogeographic distribution ... Thursday in the journal Science . The ... a neutral agent-based model"was co-authored by Ferdi Hellweger, ... of civil and environmental engineering; his doctoral student ...
(Date:9/11/2014)... Sept. 11, 2014 /PRNewswire-iReach/ -- Today at the TEDMED ... patient portal that puts genome sequencing results at the ... and actionable. The $1000 was announced earlier ... to be the tipping point towards widespread adoption of ... billion letters and 4 million variants per human genome, ...
(Date:9/11/2014)... 2014 NXT-ID, Inc. (Nasdaq: NXTD ), ... market, announced today that its shares of common stock and ... Nasdaq Capital Market. The common stock and warrants and will ... today, the Company,s common stock will no longer be quoted ... will now be traded on Nasdaq. About ...
Breaking Biology News(10 mins):Microbes evolve faster than ocean can disperse them 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 3
... irritants such as air pollution and cigarette smoke cause people ... Journal of Respiratory and Critical Care Medicine . The authors ... of Hull, have identified the reaction inside the lungs that ... irritants in the air. They suggest that their findings may ...
... release is available in German . ... in the atmosphere where it contributes to global warming. The ... as forests, grasslands and peat-lands. Stimulating this "free service" of ... immediately available ways of reducing climate change. However, new greenhouse ...
... A butterfly,s proboscis looks like a straw -- long, slender, ... a paper towel, according to Konstantin Kornev of Clemson University. ... insect anatomy to make small probes that can sample the ... next week at the 62nd Annual Meeting of the American ...
Cached Biology News:Research reveals exactly how coughing is triggered by environmental irritants 2Intensive land management leaves Europe without carbon sinks 2
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
Biology Products: